Anthony Polverino
2020 - Zymeworks
In 2020, Anthony Polverino earned a total compensation of $1.9M as Former Executive VP, Early Development & Chief Scientific Officer at Zymeworks, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,360 |
|---|---|
| Option Awards | $1,033,233 |
| Salary | $428,000 |
| Stock Awards | $264,000 |
| Other | $20,348 |
| Total | $1,903,941 |
Polverino received $1M in option awards, accounting for 54% of the total pay in 2020.
Polverino also received $158.4K in non-equity incentive plan, $428K in salary, $264K in stock awards and $20.3K in other compensation.
Rankings
In 2020, Anthony Polverino's compensation ranked 5,733rd out of 13,090 executives tracked by ExecPay. In other words, Polverino earned more than 56.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,733 out of 13,090 | 56th |
Division Manufacturing | 2,364 out of 5,621 | 58th |
Major group Chemicals And Allied Products | 945 out of 2,254 | 58th |
Industry group Drugs | 819 out of 1,954 | 58th |
Industry Pharmaceutical Preparations | 610 out of 1,459 | 58th |
Source: SEC filing on November 25, 2022.
Polverino's colleagues
We found three more compensation records of executives who worked with Anthony Polverino at Zymeworks in 2020.